Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:109 (19 January), doi:10.1136/bmj.39458.462338.3A
| The first 150 words of the full text of this article appear below. |
Forgacs and Loganayagam described the problem of overprescribing proton pump inhibitors (PPIs).1 In June 2002 we wrote to many journals—and were ignored—about long term side effects being identified in general practice and surgery patients, with the then extensive, long term use of PPIs. At the time we shared an increasing number of patients with dependence on PPIs who experienced acute, severe gastritis and gastro-oesophageal reflux if they suddenly stopped or missed their PPIs; some showed refractory gastroparesis and severely delayed jejuno-ileal and colonic peristalsis when trying to reduce or stop their treatment after taking the PPI for extended periods (>3-60 months).
PPIs block the normal homoeostasis of the gastro-jejuno-ileal-colonic function (owing to their very specific, acid production blocking only, cellular-molecular actions:they block only the cellular or molecular acid production and allow secondary build up or excessive reduction of the hormones gastrin, cholecystokinin, secretin, glucagon, motilin, VIP, substance P, somatostatin, and
A Breck McKay, family physician, Daryl Wall, director of surgery
1 PO Box 144, Carina, Qld 4152, Australia, 2 Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Qld 4102
mckay@bigpond.net.au